|
WO2000004875A2
(en)
*
|
1998-07-24 |
2000-02-03 |
Seo Hong Yoo |
Preparation of aqueous clear solution dosage forms with bile acids
|
|
JP2002522381A
(ja)
*
|
1998-08-06 |
2002-07-23 |
ストレンメル，ボルフガング |
粘膜保護用医薬としてのホスファチジルコリン
|
|
MXPA02003321A
(es)
*
|
1999-09-28 |
2004-09-10 |
Panacea Biotec Ltd |
Composiciones de liberacion controlada que comprenden nimesulida.
|
|
US7053076B2
(en)
|
2001-08-29 |
2006-05-30 |
Xenoport, Inc. |
Bile-acid derived compounds for enhancing oral absorption and systemic bioavailability of drugs
|
|
CA2503811A1
(en)
*
|
2002-11-01 |
2004-05-21 |
James Kaput |
Identification of diet-regulated disease-associated genes
|
|
US20090074785A1
(en)
*
|
2007-01-16 |
2009-03-19 |
Smith Jeffrey W |
Compositions and methods for treatment of colorectal cancer
|
|
EP2255813A1
(en)
*
|
2009-05-29 |
2010-12-01 |
The Royal College of Surgeons in Ireland |
Derivatives of ursodeoxycholic acid for the treatment of diarrhoea
|
|
ES2687027T3
(es)
|
2010-11-04 |
2018-10-23 |
Albireo Ab |
Inhibidores de ibat para el tratamiento de enfermedades hepáticas
|
|
KR102560954B1
(ko)
|
2014-06-25 |
2023-07-31 |
이에이 파마 가부시키가이샤 |
고형 제제 및 그의 착색 방지 또는 착색 감소 방법
|
|
US10441604B2
(en)
|
2016-02-09 |
2019-10-15 |
Albireo Ab |
Cholestyramine pellets and methods for preparation thereof
|
|
US10786529B2
(en)
|
2016-02-09 |
2020-09-29 |
Albireo Ab |
Oral cholestyramine formulation and use thereof
|
|
US10441605B2
(en)
|
2016-02-09 |
2019-10-15 |
Albireo Ab |
Oral cholestyramine formulation and use thereof
|
|
EP3664781A1
(en)
|
2017-08-09 |
2020-06-17 |
Albireo AB |
Cholestyramine granules, oral cholestyramine formulations and use thereof
|
|
WO2019234077A1
(en)
|
2018-06-05 |
2019-12-12 |
Albireo Ab |
Benzothia(di)azepine compounds and their use as bile acid modulators
|
|
US10793534B2
(en)
|
2018-06-05 |
2020-10-06 |
Albireo Ab |
Benzothia(di)azepine compounds and their use as bile acid modulators
|
|
CA3100687A1
(en)
|
2018-06-20 |
2019-12-26 |
Albireo Ab |
Pharmaceutical formulation of odevixibat
|
|
US11801226B2
(en)
|
2018-06-20 |
2023-10-31 |
Albireo Ab |
Pharmaceutical formulation of odevixibat
|
|
GB201812382D0
(en)
|
2018-07-30 |
2018-09-12 |
Nzp Uk Ltd |
Compounds
|
|
US11007142B2
(en)
|
2018-08-09 |
2021-05-18 |
Albireo Ab |
Oral cholestyramine formulation and use thereof
|
|
US10722457B2
(en)
|
2018-08-09 |
2020-07-28 |
Albireo Ab |
Oral cholestyramine formulation and use thereof
|
|
US11549878B2
(en)
|
2018-08-09 |
2023-01-10 |
Albireo Ab |
In vitro method for determining the adsorbing capacity of an insoluble adsorbant
|
|
CR20210458A
(es)
|
2019-02-06 |
2021-11-04 |
Albireo Ab |
Compuestos de benzotiadiazepina y su uso como moduladores del ácido biliar
|
|
US10975045B2
(en)
|
2019-02-06 |
2021-04-13 |
Aibireo AB |
Benzothiazepine compounds and their use as bile acid modulators
|
|
US10941127B2
(en)
|
2019-02-06 |
2021-03-09 |
Albireo Ab |
Benzothiadiazepine compounds and their use as bile acid modulators
|
|
ES3029063T3
(en)
|
2019-12-04 |
2025-06-23 |
Albireo Ab |
Benzothiadiazepine compounds and their use as bile acid modulators
|
|
JP7696897B2
(ja)
|
2019-12-04 |
2025-06-23 |
アルビレオ・アクチボラグ |
ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
|
|
JP7696898B2
(ja)
|
2019-12-04 |
2025-06-23 |
アルビレオ・アクチボラグ |
ベンゾチア（ジ）アゼピン化合物及び胆汁酸モジュレータとしてのそれらの使用
|
|
US11014898B1
(en)
|
2020-12-04 |
2021-05-25 |
Albireo Ab |
Benzothiazepine compounds and their use as bile acid modulators
|
|
DK4069360T3
(da)
|
2019-12-04 |
2024-02-26 |
Albireo Ab |
Benzothia(di)azepinforbindelser og anvendelse deraf som galdesyremodulatorer
|
|
EP4188541B1
(en)
|
2020-08-03 |
2024-12-25 |
Albireo AB |
Benzothia(di)azepine compounds and their use as bile acid modulators
|
|
KR20230106651A
(ko)
|
2020-11-12 |
2023-07-13 |
알비레오 에이비 |
진행성 가족성 간내 담즙정체증(pfic)을 치료하기 위한 오데빅시바트
|
|
AU2021390172A1
(en)
|
2020-12-04 |
2023-06-22 |
Albireo Ab |
Benzothia(di)azepine compounds and their use as bile acid modulators
|
|
TW202313579A
(zh)
|
2021-06-03 |
2023-04-01 |
瑞典商艾爾比瑞歐公司 |
苯并噻(二)氮呯(benzothia(di)azepine)化合物及其作為膽酸調節劑之用途
|